BAYER AKTIENGESELLSCHAFT The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish 29/08/2016 09:55 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Real-World Data from Multiple Countries Continue to Reaffirm Positive Benefit-Risk Profile of Bayer’s Xarelto® in Everyday Clinical Practice Register number: 242216